PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025: directors' dealings · Italy · Consob

Explore the full management transaction log of PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025, a publicly traded company based in Italy. Shares are listed on IT IT, under the authority of Consob. Operating in the Healthcare sector, PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 has published 1 reports. Market capitalisation: €861.8m. The latest transaction was disclosed on 10 November 2025 — Other. Among the most active insiders: Unknown. The full history is free.